Pulse Brain · Growing Health Evidence Index
Tier 3 — Observational / field trialPeer-reviewed

Inflammatory Biomarkers and Risk of Schizophrenia

Fernando Pires Hartwig, Maria Carolina Borges, Bernardo Lessa Horta, Jack Bowden, George Davey Smith

JAMA Psychiatry · 2017

Read source ↗ All evidence

Summary

This two-sample mendelian randomization study leveraged genetic variants as instrumental variables to investigate whether inflammatory biomarkers causally influence schizophrenia risk, addressing limitations of conventional observational studies prone to reverse causation and confounding. Using summary association results from large consortia with gene-inflammatory biomarker associations estimated in pooled samples up to 80,000 individuals and gene-schizophrenia associations in over 75,000 participants, the authors examined three inflammatory markers: C-reactive protein, interleukin-1 receptor antagonist, and soluble interleukin-6 receptor. Results suggested a protective association between genetically elevated C-reactive protein and schizophrenia risk (pooled OR 0.90 per 2-fold increment, 95% CI 0.84–0.97), contrary to observational findings, with consistent estimates across different mendelian randomization methods.

UK applicability

The findings are relevant to UK psychiatric and public health research, as the study populations were predominantly of European ancestry, which aligns with UK demographics. However, the causal conclusions challenge observational associations previously reported in European populations, suggesting that inflammatory markers alone may not be direct drivers of schizophrenia risk and that UK clinical practice should not prioritise inflammation reduction specifically as a schizophrenia prevention strategy based on this evidence.

Key measures

Pooled odds ratio estimates per 2-fold increment in inflammatory biomarker levels; genetic instruments (18 CRP instruments used); schizophrenia cases (>30,000) and controls (>45,000)

Outcomes reported

The study evaluated whether genetically elevated circulating levels of inflammatory biomarkers (C-reactive protein, interleukin-1 receptor antagonist, and soluble interleukin-6 receptor) causally influence the risk of developing schizophrenia. Risk of schizophrenia was measured as the primary outcome across pooled genetic consortia data.

Theme
Nutrition & health
Subject
Other / interdisciplinary
Study type
Research
Study design
Two-sample mendelian randomization study
Source type
Peer-reviewed study
Status
Published
Geography
International
System type
Human clinical
DOI
10.1001/jamapsychiatry.2017.3191
Catalogue ID
BFmor3gaas-7mya4s

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.